Biopharmaceuticals & Biotechnology Company | BioGenomics
Home
EXPLORE
Ability to explore Biopharmaceuticals with a
meaningful and lasting impact on quality of life
ANALYZE
Thoroughly evaluate probable solutions through
a deep understanding of science and technology
INNOVATE
Research path breaking processes and products through innovation at every stage
INSPIRE
Generate a basket of unique medicines that transform healthcare and inspire future innovations
Empowered through research. Enriched through innovation
Indigenous to the core
Completely indigenous technology at each stage of development, including cell lines and process development.
All manufacturing processes established for robustness, using modern ‘Quality by Design’ concepts.
International standard clinical safety and efficacy trials
EMA and GCP compliant clinical studies.
Statistically significant and meaningful clinical trials.
Clinical trials aimed at establishing biosimilarity, immunogenicity and efficacy using globally sourced reference products.
Quality that matches only the best
BioGenomics establishes biosimilarity by a thorough characterization process, using modern technologies which are compliant with global regulatory requirements.
Animal-origin free products.
cGMP Production Facility
WHO GMP certified. Advanced formulation capabilities. ISO 9001:2015, ISO 14001 and
ISO 18001. Aiming to be FDA facility.
Strong IP portfolio for Value Creation
BioGenomics’ innovations cover super vectors for mammalian and microbial expressions, codon optimized gene sequences, protein folding technologies, novel purification and isolation technologies.
Founded by technocrats with MNC experience. Headquarter near Mumbai, India.
Fully equipped, Department of Scientific & Industrial Research (DSIR) approved,
Good Laboratory Practices (GLP) compliant research and development centre near Mumbai, India, (ISO 9001:2015, ISO:140001, ISO:18001 certified).
State of the art Good Manufacturing Practices (GMP) manufacturing and fill + finish facilities in Pondicherry, India.
Partnering with Leaders
BioGenomics is partnering country specific pharmaceutical segment leaders for each class of products. Its partnerships ensure mutual success through joint investments in products, enable competitive pricing and effectively facilitate mutually beneficial partnering models.
